A mini-review of Nanocarriers in drug delivery systems

The application of nanotechnology indrug delivery systems (DDS) has been researched widely and seen an advancementover the past three decades. Since 1970s, nanoparticles were primarilyutilised in vaccine deliveries cancer chemotherapy. In more recent years,they have found to hold promises for broader applications such as inproteins therapeutic gene systems. To date, there only ahandful nanocarrier-loaded drugs commercialised into pharmaceuticalmarket. More research is thus needed facilitate a breakthrough theseproducts current market. This mini-review mainly focuses on four typesof commonly utilised organic nanocarriers including micelles, compactpolymerics, solid-lipid liposomal vesicles discusses theprogress some challenges associated with these (NP).